Monoclonal antibodies can block a key immune-related protein that drives the spread of brain cell damage in Parkinson's disease (PD). This protein, called glycoprotein nonmetastatic melanoma B (GPNMB), might be part of a ...
May 13, 2026
0
12
A type of drug used to prevent migraine may be associated with a reduced risk of glaucoma, according to a study published in Neurology. The study compared 36,822 people who took calcitonin gene-related peptide (CGRP) inhibitor ...
May 6, 2026
0
11
Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of cancer, neurodegenerative ...
Feb 21, 2026
0
73
Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for protection against two common viruses. The proposed preventative treatment consists of antibodies identified ...
Cancer researchers working on immunotherapies have made a big discovery: SLAMF6, a molecule on the surface of immune cells that prevents T cells from effectively attacking tumors—and, in mice, they've found a way to neutralize ...
Feb 12, 2026
0
33
Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become increasingly common in recent years. A research team from The Hong Kong Polytechnic University (PolyU) has ...
Feb 3, 2026
0
9
Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick up the medicine every few weeks. It would be easier for them to be able to inject the medicine themselves ...
Jan 16, 2026
0
15
To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri has put tumors under a spotlight.
Jan 7, 2026
0
9
A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new study says.
Dec 20, 2025
0
24
Researchers at Kumamoto University have discovered a monoclonal antibody capable of neutralizing a wide range of SARS-CoV-2 variants, including the elusive omicron subvariants. This antibody, named K4-66, was isolated from ...
Dec 2, 2024
0
47
